<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03336489</url>
  </required_header>
  <id_info>
    <org_study_id>HPD_2016_24</org_study_id>
    <nct_id>NCT03336489</nct_id>
  </id_info>
  <brief_title>Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks</brief_title>
  <acronym>DICODOM</acronym>
  <official_title>Evaluation of the Organization of Continuity of Care for Home Hospice Patients by Four Parisian Health Networks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In Paris, France, home hospice care for terminally ill patients is organized by four
      &quot;palliative care networks&quot;. These networks are responsible for information sharing and
      coordination of all health care professionals working with the patient. Two different systems
      are in place to ensure continuity of care outside working hours, in such a setting. In the
      first system, palliative care specialists from the network are reachable over the phone 24/7
      by the patient or its caregivers, whenever needed. In the second system, medical information
      about the patient, regularly updated by the network's medical team, is available to
      professionals via a secure website, so that in case the patient requires an urgent medical
      home visit outside working hours, the visiting physician has access to accurate information.

      The study's goal is to compare patient's and caregiver's satisfaction between these two
      systems of continuity of care.

      For that purpose, patients will be taken care of as usual by every palliative care network.
      In every instance where the patient or caregivers have reached out for medical help through
      the network's continuity of care system, the patient or caregiver will be called 5 days later
      by the investigation team to go through a satisfaction questionnaire (Likert scales)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2017</start_date>
  <completion_date type="Anticipated">January 29, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 29, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction about the response given by the network's continuity of care system</measure>
    <time_frame>between the first and tenth day after the patient or caregiver activated the network's continuity of care system</time_frame>
    <description>Patient's (or caregiver's) satisfaction about the response given by the network's continuity of care system, after the patient or caregiver activated this system at night time or during week-ends or bank holliday, as measured on a 4-level Likert scale (verbal questionnaire by phone call)</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Neoplasms</condition>
  <condition>Neurodegenerative Diseases</condition>
  <condition>Terminal Illness</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients newly followed for home hospice care by the four palliative care networks of
        Paris, France, during the inclusion period (up to the inclusion of 200 patients)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient has a disease with fatal prognosis and requires palliative care

          -  Patient lives in Paris, France

          -  Patient benefits from home hospice care through one of the four official Paris
             palliative care networks

        Exclusion Criteria:

          -  Pregnant women

          -  Breastfeeding womed

          -  Altered cognitive function with a Mini Mental Status below 20

          -  Patient not able to communicate or not speaking French

          -  Patient legally not capable of giving informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Herve PICARD, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Research Department, Rothschild Foundation, Paris (France)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Herve PICARD, MD MSc</last_name>
    <phone>0033148036431</phone>
    <email>hpicard@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Laurence SALOMON, MD PhD</last_name>
    <phone>0033148036431</phone>
    <email>lsalomon@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Reseau QUIETUDE</name>
      <address>
        <city>Paris</city>
        <zip>75003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herve PICARD, MD, MSc</last_name>
      <email>hpicard@for.paris</email>
    </contact>
    <contact_backup>
      <last_name>Laurence SALOMON, MD, PhD</last_name>
      <email>lsalomon@for.paris</email>
    </contact_backup>
    <investigator>
      <last_name>Francis DIEZ, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Térence LANDRIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reseaux ROPE</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herve PICARD, MD, MSc</last_name>
      <email>hpicard@for.paris</email>
    </contact>
    <contact_backup>
      <last_name>Laurence SALOMON, MD, PhD</last_name>
      <email>lsalomon@for.paris</email>
    </contact_backup>
    <investigator>
      <last_name>Mélanie NUIZIERE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Céline LAOUISSET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reseau ENSEMBLE</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herve PICARD, MD, MSc</last_name>
      <email>hpicard@for.paris</email>
    </contact>
    <contact_backup>
      <last_name>Laurence SALOMON, MD, PhD</last_name>
      <email>lsalomon@for.paris</email>
    </contact_backup>
    <investigator>
      <last_name>Marianne ROTH, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arnaud LEYS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reseaux ParisOuest</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herve PICARD, MD, MSc</last_name>
      <email>hpicard@for.paris</email>
    </contact>
    <contact_backup>
      <last_name>Laurence SALOMON, MD, PhD</last_name>
      <email>lsalomon@for.paris</email>
    </contact_backup>
    <investigator>
      <last_name>France VAUTIER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virginie VIGIER DE LA ROCHEFOUCAULD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 5, 2017</study_first_submitted>
  <study_first_submitted_qc>November 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2017</study_first_posted>
  <last_update_submitted>November 7, 2017</last_update_submitted>
  <last_update_submitted_qc>November 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurodegenerative Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

